Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin-induced thrombocytopenia.

D R Baldwin

    Journal of Intravenous Nursing : the Official Publication of the Intravenous Nurses Society
    |November 1, 1989
    PubMed
    Summary

    Heparin-induced thrombocytopenia (HIT) is a rare but serious complication. All patients receiving heparin should be monitored for HIT due to unpredictable onset and lack of risk factors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effective management of incidental findings in lung cancer screening: the role of the screening review meeting.

    Clinical radiology·2025
    Same author

    Pulmonary nodules.

    BMJ (Clinical research ed.)·2020
    Same author

    Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening.

    European journal of radiology·2019
    Same author

    Lung cancer screening - gaining consensus on next steps - proceedings of a closed workshop in the UK.

    Lung cancer (Amsterdam, Netherlands)·2018
    Same author

    Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

    Pilot and feasibility studies·2016
    Same author

    The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

    Pilot and feasibility studies·2016

    Area of Science:

    • Cardiology
    • Hematology
    • Pharmacology

    Background:

    • Adverse reactions to heparin are uncommon but can be serious.
    • Heparin-induced thrombocytopenia (HIT) affects up to 30% of patients.
    • HIT presents in two distinct types with differing clinical implications.

    Purpose of the Study:

    • To differentiate the two types of heparin-induced thrombocytopenia.
    • To highlight the clinical significance and risk factors associated with HIT.
    • To emphasize the need for vigilance in all patients receiving heparin.

    Main Methods:

    • Review of recent studies on heparin complications.
    • Analysis of clinical presentation and etiological differences between HIT types.
    • Identification of diagnostic indicators and therapeutic considerations.

    Main Results:

    • Type 1 HIT: Mild, transient thrombocytopenia (days 2-3), often self-reversing.
    • Type 2 HIT: Immune-mediated, potentially life-threatening (days 4-8), associated with white clot syndrome.
    • HIT is independent of patient age, sex, blood type, or heparin dose.

    Conclusions:

    • Heparin-induced thrombocytopenia is a critical complication requiring awareness.
    • All patients on heparin therapy are at risk, necessitating close monitoring.
    • Early recognition and differentiation of HIT types are crucial for patient management.

    Related Experiment Videos